Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Cash on Hand 2010-2023 | MKGAF

Merck cash on hand from 2010 to 2023. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
  • Merck cash on hand for the quarter ending September 30, 2023 was $2.811B, a 43.07% increase year-over-year.
  • Merck cash on hand for 2022 was $2.292B, a 6.56% decline from 2021.
  • Merck cash on hand for 2021 was $2.453B, a 45.07% increase from 2020.
  • Merck cash on hand for 2020 was $1.691B, a 80.13% increase from 2019.
  
Merck Annual Cash on Hand
(Millions of US $)
2022 $2,292
2021 $2,453
2020 $1,691
2019 $939
2018 $2,591
2017 $767
2016 $1,200
2015 $1,175
2014 $6,750
2013 $4,505
2012 $3,251
2011 $2,862
2010 $
2009 $
Merck Quarterly Cash on Hand
(Millions of US $)
2023-09-30 $2,811
2023-06-30 $2,101
2023-03-31 $1,847
2022-12-31 $2,292
2022-09-30 $1,965
2022-06-30 $1,823
2022-03-31 $1,622
2021-12-31 $2,453
2021-09-30 $1,963
2021-06-30 $2,253
2021-03-31 $2,770
2020-12-31 $1,691
2020-09-30 $1,909
2020-06-30 $1,700
2020-03-31 $1,777
2019-12-31 $939
2019-09-30 $5,989
2019-06-30 $4,051
2019-03-31 $2,730
2018-12-31 $2,591
2018-09-30 $1,039
2018-06-30 $869
2018-03-31 $1,007
2017-12-31 $767
2017-09-30 $1,114
2017-06-30 $1,245
2017-03-31 $1,220
2016-12-31 $1,200
2016-09-30 $1,076
2016-06-30 $934
2016-03-31 $1,089
2015-12-31 $1,175
2015-09-30 $12,938
2015-06-30 $9,605
2015-03-31 $8,849
2014-12-31 $6,750
2014-09-30 $3,523
2014-06-30 $2,473
2014-03-31 $5,121
2013-12-31 $4,505
2013-09-30 $4,381
2013-06-30 $4,344
2013-03-31 $3,832
2012-12-31 $3,251
2012-09-30 $3,663
2012-06-30 $2,859
2012-03-31
2011-12-31 $2,862
2011-09-30
2011-06-30 $2,471
2011-03-31
2010-12-31
2010-09-30 $1,913
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $21.132B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $68.595B 28.19
Chugai Pharmaceutical (CHGCY) Japan $54.482B 23.66
Takeda Pharmaceutical (TAK) Japan $42.314B 6.86
Astellas Pharma (ALPMY) Japan $17.282B 24.49
Shionogi (SGIOY) Japan $14.459B 12.51
Neurocrine Biosciences (NBIX) United States $13.400B 55.65
Sandoz Group AG (SDZNY) $12.650B 0.00
United Therapeutics (UTHR) United States $10.945B 11.72
Catalent (CTLT) United States $10.176B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.599B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.967B 7.07
Ionis Pharmaceuticals (IONS) United States $6.084B 0.00
Revolution Medicines (RVMD) United States $5.940B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.341B 0.00
Orion OYJ (ORINY) Finland $5.081B 21.43
Madrigal Pharmaceuticals (MDGL) United States $4.708B 0.00
Alpine Immune Sciences (ALPN) United States $4.219B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.103B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.060B 0.00
Indivior (INDV) United States $2.664B 12.39
Evotec AG (EVO) Germany $2.583B 0.00
Summit Therapeutics (SMMT) United States $2.572B 0.00
Corcept Therapeutics (CORT) United States $2.434B 24.75
Dyne Therapeutics (DYN) United States $2.228B 0.00
PTC Therapeutics (PTCT) United States $2.024B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.973B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.805B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.796B 18.56
NewAmsterdam Pharma (NAMS) Netherlands $1.759B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.695B 10.04
Ardelyx (ARDX) United States $1.643B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.580B 27.66
Avadel Pharmaceuticals (AVDL) Ireland $1.448B 0.00
4D Molecular Therapeutics (FDMT) United States $1.348B 0.00
Xencor (XNCR) United States $1.252B 0.00
Pacira BioSciences (PCRX) United States $1.248B 12.42
Ironwood Pharmaceuticals (IRWD) United States $1.233B 11.59
Soleno Therapeutics (SLNO) United States $1.206B 0.00
Ocular Therapeutix (OCUL) United States $1.188B 0.00
Collegium Pharmaceutical (COLL) United States $1.168B 7.19
Centessa Pharmaceuticals (CNTA) United Kingdom $1.135B 0.00
Cassava Sciences (SAVA) United States $0.984B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.983B 0.00
Cronos Group (CRON) Canada $0.959B 0.00
Sage Therapeutics (SAGE) United States $0.928B 0.00
Relay Therapeutics (RLAY) United States $0.922B 0.00
ARS Pharmaceuticals (SPRY) United States $0.870B 0.00
Enliven Therapeutics (ELVN) United States $0.869B 0.00
USANA Health Sciences (USNA) United States $0.846B 13.32
Lyell Immunopharma (LYEL) United States $0.765B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.738B 0.00
Savara (SVRA) United States $0.700B 0.00
Silence Therapeutics (SLN) United Kingdom $0.664B 0.00
Verve Therapeutics (VERV) United States $0.636B 0.00
Siga Technologies (SIGA) United States $0.626B 9.27
Korro Bio (KRRO) United States $0.601B 0.00
OmniAb (OABI) United States $0.591B 0.00
Altimmune (ALT) United States $0.566B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.566B 0.00
Exscientia (EXAI) United Kingdom $0.563B 0.00
Tourmaline Bio (TRML) United States $0.517B 0.00
KalVista Pharmaceuticals (KALV) United States $0.502B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.467B 0.00
Harrow (HROW) United States $0.447B 0.00
Larimar Therapeutics (LRMR) United States $0.444B 0.00
Heron Therapeutics (HRTX) United States $0.437B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.429B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.413B 0.00
Esperion Therapeutics (ESPR) United States $0.405B 0.00
Lexeo Therapeutics (LXEO) United States $0.403B 0.00
ProKidney (PROK) United States $0.401B 0.00
Organogenesis (ORGO) United States $0.380B 72.00
Bioventus (BVS) United States $0.362B 0.00
Nature's Sunshine Products (NATR) United States $0.358B 20.02
Enanta Pharmaceuticals (ENTA) United States $0.348B 0.00
ESSA Pharma (EPIX) Canada $0.343B 0.00
Metagenomi (MGX) United States $0.336B 0.00
Foghorn Therapeutics (FHTX) United States $0.316B 0.00
Lyra Therapeutics (LYRA) United States $0.315B 0.00
Fractyl Health (GUTS) United States $0.312B 0.00
Prelude Therapeutics (PRLD) United States $0.309B 0.00
Nektar Therapeutics (NKTR) United States $0.307B 0.00
Akebia Therapeutics (AKBA) United States $0.306B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.291B 0.00
Nanobiotix S.A (NBTX) France $0.287B 0.00
Aquestive Therapeutics (AQST) United States $0.287B 0.00
Pyxis Oncology (PYXS) United States $0.286B 0.00
Adherex Technologies (FENC) United States $0.284B 0.00
Black Diamond Therapeutics (BDTX) United States $0.271B 0.00
Xeris Biopharma Holdings (XERS) United States $0.268B 0.00
Telomir Pharmaceuticals (TELO) United States $0.266B 0.00
Avita Medical (RCEL) United States $0.254B 0.00
Century Therapeutics (IPSC) United States $0.253B 0.00
Aldeyra Therapeutics (ALDX) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Conduit Pharmaceuticals (CDT) United States $0.232B 0.00
Acrivon Therapeutics (ACRV) United States $0.226B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.210B 0.00
Zevra Therapeutics (ZVRA) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.193B 0.00
Incannex Healthcare (IXHL) Australia $0.189B 0.00
Regulus Therapeutics (RGLS) United States $0.183B 0.00
VAXART, INC (VXRT) United States $0.158B 0.00
CytoDyn (CYDY) United States $0.156B 0.00
GlycoMimetics (GLYC) United States $0.155B 0.00
Inotiv (NOTV) United States $0.154B 0.00
MediWound (MDWD) Israel $0.152B 0.00
Elite Pharmaceuticals (ELTP) United States $0.150B 14.00
Achieve Life Sciences (ACHV) Canada $0.149B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.142B 3.00
Karyopharm Therapeutics (KPTI) United States $0.140B 0.00
Relmada Therapeutics (RLMD) United States $0.140B 0.00
OptiNose (OPTN) United States $0.137B 0.00
FibroGen (FGEN) United States $0.128B 0.00
Cardiol Therapeutics (CRDL) Canada $0.127B 0.00
Citius Pharmaceuticals (CTXR) United States $0.125B 0.00
Eliem Therapeutics (ELYM) United States $0.119B 0.00
ProPhase Labs (PRPH) United States $0.118B 0.00
Vivani Medical (VANI) United States $0.114B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.103B 0.00
PMV Pharmaceuticals (PMVP) United States $0.092B 0.00
AlloVir (ALVR) United States $0.088B 0.00
Journey Medical (DERM) United States $0.088B 0.00
Aclaris Therapeutics (ACRS) United States $0.086B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.68
Carisma Therapeutics (CARM) United States $0.080B 0.00
Tempest Therapeutics (TPST) United States $0.080B 0.00
Mural Oncology (MURA) $0.071B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.057B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.81
Gain Therapeutics (GANX) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.049B 0.00
Viracta Therapeutics (VIRX) United States $0.045B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
VYNE Therapeutics (VYNE) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.035B 0.00
Nutriband (NTRB) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.034B 0.00
Lipocine (LPCN) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Aptorum Group (APM) United Kingdom $0.029B 0.00
Addex Therapeutics (ADXN) Switzerland $0.027B 0.00
CERo Therapeutics Holdings (CERO) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Alaunos Therapeutics (TCRT) United States $0.026B 0.00
JanOne (JAN) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Jaguar Animal Health (JAGX) United States $0.025B 0.00
DURECT (DRRX) United States $0.024B 0.00
Indaptus Therapeutics (INDP) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.87
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Surrozen (SRZN) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.10
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Dominari Holdings (DOMH) United States $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Inhibikase Therapeutics (IKT) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Biomerica (BMRA) United States $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Clever Leaves Holdings (CLVR) Canada $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
XORTX Therapeutics (XRTX) Canada $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Universe Pharmaceuticals INC (UPC) China $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.006B 0.00
Petros Pharmaceuticals (PTPI) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.17
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 47.40